← All trials
NCT04430777
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 17, 2019
- Primary completion
- Feb 22, 2020
- Completion date
- Feb 22, 2020
- First posted
- Jun 12, 2020
- Last posted
- Jun 12, 2020
- Enrollment
- 141
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Total Definer Research GroupLead sponsor
- Total Definer Research GroupReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.